predicting which Stage IVs will respond best to lapatinib+capecitabine

[Lani]

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0039943

It appears the higher the level of her2 and the higher the level of her3, the better the response

[Rolepaul]

I hope the doctors that are treating HER+ patients read this. I do not know how many look at HER2, HER3, and 95HER2 marker testing. I will see whether they did this with Nina as the Xeloda/Tykerb mix stabilized the disease in the brain. Nina has never had disease seen elsewhere, although blood cells and markers in the blood showed that there was a potential for that to occur.

As Always, thank you Lani for your work in this area.